On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.
A University of the Pacific team has developed a single-dose injection to counter the effects of fentanyl and other opioid ...
Mounjaro comes as a solution in a single-dose pen. You’ll administer Mounjaro weekly as a subcutaneous injection. You can take your dose with or without food. The drug’s manufacturer provides ...
The Stockton Record on MSN10d
University of the Pacific team develops single-dose antidote to combat fentanyl overdosesA professor and his team at University of the Pacific have developed a single-dose treatment that provides extended ...
The new single-injection dosage was approved on Oct. 14, 2024, based on studies that evaluated the bioequivalence of the drug’s 320 mg dose given as a 2 mL subcutaneous injection vs. two 1 mL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback